Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:developedBy |
aldoxorubicin
|
| gptkbp:focusesOn |
oncology
cancer therapeutics |
| gptkbp:formerName |
gptkb:CytRx_Corporation
|
| gptkbp:foundedYear |
1985
|
| gptkbp:headquartersLocation |
gptkb:Los_Angeles,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
LadRx Corporation
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:stockSymbol |
gptkb:LADX
|
| gptkbp:tradedOn |
gptkb:OTCQB
|
| gptkbp:website |
https://www.ladrxcorp.com/
|
| gptkbp:bfsParent |
gptkb:Phillip_Frost
|
| gptkbp:bfsLayer |
6
|